• 896 Citations
  • 14 h-Index
19962019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 896 Citations
  • 14 h-Index
  • 108 Article
  • 10 Review article
  • 1 Short survey

ACT001 can prevent and reverse tamoxifen resistance in human breast cancer cell lines by inhibiting NF-κB activation

Jin, X. H., Jia, Y. S., Shi, Y. H., Li, Q. Y., Bao, S. Q., Lu, W. P. & Tong, Z., Feb 1 2019, In : Journal of cellular biochemistry. 120, 2, p. 1386-1397 12 p.

Research output: Contribution to journalArticle

Tamoxifen
Chemical activation
Cells
Breast Neoplasms
Cell Line

Advances in chemoprevention of breast cancer

Ren, Y., Jia, Y. & Tong, Z., Jun 1 2018, In : Tumor. 38, 6, p. 617-622 6 p., 803.

Research output: Contribution to journalReview article

Chemoprevention
Selective Estrogen Receptor Modulators
Aromatase Inhibitors
Breast Neoplasms
Women's Health

Advances in drug resistance mechanism of immunologic checkpoint blockers and related reveral treatment

Shi, Y. & Tong, Z., Jan 1 2018, In : Chinese Journal of Clinical Oncology. 45, 15, p. 812-815 4 p.

Research output: Contribution to journalArticle

Drug Resistance
Immunotherapy
Radiotherapy
Drug Therapy
Drug Combinations

Advances in epigenetic mechanism and drug research of reversing resistance to endocrine therapy in breast cancer

Zhang, J., Zhao, W. & Tong, Z., Oct 1 2018, In : Tumor. 38, 10, p. 980-986 7 p., 1000-7431(2018)10-0980-07.

Research output: Contribution to journalReview article

Epigenomics
Breast Neoplasms
Research
Estrogen Receptors
Pharmaceutical Preparations
1 Citation (Scopus)

Benefit of everolimus as a monotherapy for a refractory breast cancer patient bearing multiple genetic mutations in the PI3K/AKT/mTOR signaling pathway

Shi, Y., Zhang, W., Ye, Y., Cheng, Y., Han, L., Liu, P., Zhao, W., Tong, Z. & Yu, J., Aug 1 2018, In : Cancer Biology and Medicine. 15, 3, p. 314-321 8 p.

Research output: Contribution to journalArticle

Sirolimus
Phosphotransferases
Breast Neoplasms
Mutation
Exons